发明申请
- 专利标题: DETERMINING THE CLINICAL SIGNIFICANCE OF VARIANT SEQUENCES
- 专利标题(中): 确定变异序列的临床意义
-
申请号: US13488142申请日: 2012-06-04
-
公开(公告)号: US20130324417A1公开(公告)日: 2013-12-05
- 发明人: Caleb Kennedy , Mark Umbarger , Greg Porreca
- 申请人: Caleb Kennedy , Mark Umbarger , Greg Porreca
- 申请人地址: US MA Cambridge
- 专利权人: Good Start Genetics, Inc.
- 当前专利权人: Good Start Genetics, Inc.
- 当前专利权人地址: US MA Cambridge
- 主分类号: C12Q1/68
- IPC分类号: C12Q1/68 ; C40B20/00
摘要:
The present invention generally relates to determining the clinical significance of a variant nucleic acid sequence. The invention can involve sequencing a nucleic acid to generate at least one sequence read, identifying a variant sequence within the sequence read, determining the equivalent insertion/deletion region (EIR) of the variant sequence, identifying a functional region including at least a portion of the EIR, and associating the EIR with the identified functional region, thereby to determine the clinical significance of the variant.
信息查询